The National Agency for Food and Drug Administration and Control (NAFDAC) has issued a public alert following the recall of specific batches of Citro-Soda Regular antacid in South Africa. The recall was initiated after concerns were raised about product quality at a manufacturing facility. While the affected products were recalled in South Africa, NAFDAC is notifying healthcare professionals, distributors, and consumers in Nigeria to remain vigilant and ensure that potentially affected products do not enter the local supply chain.
What Happened?
NAFDAC announced that it had received notification from the South African Health Products Regulatory Authority (SAHPRA) regarding the recall of specific batches of Citro-Soda Regular antacid. The recall was linked to concerns identified during an inspection of the Adcock Ingram Clayville manufacturing facility in Johannesburg.
The affected products include all Citro-Soda Regular batches with batch numbers beginning with the letter “C” and expiry dates on or before November 2027. The recall covers the 60g, 120g, and 4g x 30 sachet pack sizes. Regulatory authorities have advised distributors, retailers, and consumers to stop using and distributing the affected batches.
Why It Matters To Your Health
Citro-Soda is a commonly used antacid that helps relieve symptoms such as indigestion, heartburn, acid discomfort, and stomach upset. Many consumers rely on the product for quick relief from digestive symptoms.
When concerns arise about manufacturing quality, regulators may initiate recalls to prevent potentially substandard products from reaching patients. Substandard medicines may not perform as intended and, depending on the nature of the defect, could potentially expose consumers to health risks. This is why health authorities take precautionary action even before widespread harm occurs.
Although the recall originated in South Africa, NAFDAC’s alert is important because products can sometimes enter other markets through unofficial distribution channels. By notifying healthcare providers and the public, regulators hope to prevent affected products from reaching Nigerian consumers.
The alert also serves as a reminder of the importance of purchasing medicines only from licensed pharmacies and authorized healthcare outlets, where product quality can be more easily verified.
What You Can Do
To protect yourself and your family:
- Check any Citro-Soda Regular products you may have at home.
- Look for batch numbers beginning with the letter “C” and expiry dates on or before November 2027.
- Avoid using any product that matches the affected recall criteria until you receive guidance from a healthcare professional.
- Purchase medicines only from licensed pharmacies and reputable healthcare providers.
- Report any suspected substandard medicines to NAFDAC through its official reporting channels.
- Consult a pharmacist if you need advice about alternative treatments for indigestion or heartburn.
If you experience unusual symptoms after taking any medicine, seek medical advice promptly.
Understanding The Issue
Medicine recalls are an important part of pharmaceutical safety systems. They occur when manufacturers or regulators identify concerns that could affect a product’s quality, safety, or effectiveness.
In this case, the recall was linked to findings from a regulatory inspection of a manufacturing facility. While authorities have not reported widespread patient harm, the recall was initiated as a precautionary measure to protect consumers and maintain confidence in medicine quality standards.
Citro-Soda contains ingredients that help neutralize excess stomach acid and relieve symptoms associated with indigestion and heartburn. It has been widely used for many years as an over-the-counter digestive remedy.
A common misconception is that medicine recalls automatically mean a product is dangerous. In reality, many recalls are precautionary and are designed to address potential issues before they lead to significant health problems. Regulatory agencies routinely monitor medicines and intervene whenever quality concerns are identified.
The recall only affects Citro-Soda Regular manufactured at the Clayville facility. Products manufactured at other Adcock Ingram facilities and Citro-Soda Cranberry products are not included in the recall.
This incident highlights the importance of strong regulatory oversight and international cooperation between agencies such as NAFDAC and SAHPRA. Sharing safety information across borders helps protect patients and ensures that potentially affected products can be identified and removed quickly from supply chains.
When To Speak With A Healthcare Professional
Speak with a pharmacist or doctor if:
- You have a recalled batch of Citro-Soda Regular and are unsure what to do.
- You need an alternative treatment for indigestion, acid reflux, or heartburn.
- You experience unusual symptoms after taking any antacid product.
- You have ongoing digestive symptoms that do not improve with treatment.
Seek urgent medical attention if you develop severe abdominal pain, persistent vomiting, difficulty swallowing, signs of an allergic reaction, or any serious symptoms after taking a medication.
Join The Me & You Pharma Community
Stay informed with trusted medication updates, health news, pharmacist-backed advice, and practical wellness tips. Join the Me & You Pharma community to access reliable health information, learn about important medicine safety alerts, and stay up to date on healthcare developments that may affect you and your family.
Medical Disclaimer
This content is provided for educational purposes only and is not intended to replace professional medical advice, diagnosis, or treatment. Always consult a qualified healthcare professional before starting, stopping, or changing any medication or treatment plan.
